rs1555889131
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000516.7(GNAS):c.432+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000516.7 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- McCune-Albright syndromeInheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- progressive osseous heteroplasiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, NO_KNOWN Submitted by: G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- pseudohypoparathyroidism type 1BInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- pseudohypoparathyroidism type 1CInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- pseudopseudohypoparathyroidismInheritance: AD, Mitochondrial Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
- pseudohypoparathyroidism type 1AInheritance: Mitochondrial, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GNAS | NM_000516.7 | c.432+1G>A | splice_donor_variant, intron_variant | Intron 5 of 12 | ENST00000371085.8 | NP_000507.1 | ||
| GNAS | NM_016592.5 | c.*338+1G>A | splice_donor_variant, intron_variant | Intron 5 of 12 | ENST00000371075.7 | NP_057676.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GNAS | ENST00000371085.8 | c.432+1G>A | splice_donor_variant, intron_variant | Intron 5 of 12 | 1 | NM_000516.7 | ENSP00000360126.3 | |||
| GNAS | ENST00000371075.7 | c.*338+1G>A | splice_donor_variant, intron_variant | Intron 5 of 12 | 1 | NM_016592.5 | ENSP00000360115.3 | |||
| GNAS | ENST00000676826.2 | c.2364+1G>A | splice_donor_variant, intron_variant | Intron 5 of 12 | ENSP00000504675.2 | |||||
| GNAS | ENST00000371102.8 | c.2319+1G>A | splice_donor_variant, intron_variant | Intron 4 of 11 | 5 | ENSP00000360143.4 | ||||
| GNAS | ENST00000354359.12 | c.435+1G>A | splice_donor_variant, intron_variant | Intron 5 of 12 | 1 | ENSP00000346328.7 | ||||
| GNAS | ENST00000371095.7 | c.390+1G>A | splice_donor_variant, intron_variant | Intron 4 of 11 | 1 | ENSP00000360136.3 | ||||
| GNAS | ENST00000470512.6 | c.258+1G>A | splice_donor_variant, intron_variant | Intron 5 of 12 | 5 | ENSP00000499552.2 | ||||
| GNAS | ENST00000480232.6 | c.258+1G>A | splice_donor_variant, intron_variant | Intron 6 of 13 | 5 | ENSP00000499545.2 | ||||
| GNAS | ENST00000663479.2 | c.258+1G>A | splice_donor_variant, intron_variant | Intron 5 of 12 | ENSP00000499353.2 | |||||
| GNAS | ENST00000462499.6 | c.213+1G>A | splice_donor_variant, intron_variant | Intron 4 of 11 | 2 | ENSP00000499758.2 | ||||
| GNAS | ENST00000467227.6 | c.213+1G>A | splice_donor_variant, intron_variant | Intron 5 of 12 | 3 | ENSP00000499681.2 | ||||
| GNAS | ENST00000478585.6 | c.213+1G>A | splice_donor_variant, intron_variant | Intron 4 of 11 | 2 | ENSP00000499762.2 | ||||
| GNAS | ENST00000481039.6 | c.213+1G>A | splice_donor_variant, intron_variant | Intron 4 of 11 | 5 | ENSP00000499767.2 | ||||
| GNAS | ENST00000485673.6 | c.213+1G>A | splice_donor_variant, intron_variant | Intron 4 of 11 | 5 | ENSP00000499334.2 | ||||
| GNAS | ENST00000488546.6 | c.213+1G>A | splice_donor_variant, intron_variant | Intron 4 of 11 | 5 | ENSP00000499332.2 | ||||
| GNAS | ENST00000492907.6 | c.213+1G>A | splice_donor_variant, intron_variant | Intron 4 of 11 | 3 | ENSP00000499443.2 | ||||
| GNAS | ENST00000453292.7 | c.*293+1G>A | splice_donor_variant, intron_variant | Intron 4 of 11 | 5 | ENSP00000392000.2 | ||||
| GNAS | ENST00000461152.6 | c.*389G>A | downstream_gene_variant | 5 | ENSP00000499274.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Pseudopseudohypoparathyroidism Pathogenic:2Other:1
The c.2361+1G>A splice-site variant affects the canonical splice donor site of intron 5 and is thus predicted to be a loss of function mutation. It has been reported as a de novo heterozygous change in a patient with pseudopseudohypoparathyroidism (Wilson et al, 1997) and is absent from the ExAC and gnomAD population databases. Sanger sequencing of the parental samples was negative for the variant indicating that this variant likely represents a de novo change in the patient. However, low level parental mosaicism cannot be excluded. Based on the combined evidence, c.2361+1G>A is classified as a pathogenic variant. -
- -
- -
not provided Pathogenic:2
Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29072892, 23281139, 25525159, 23884777, 31624069, 30577886, 31019026, 31886927, 25802881, 7853365, 35296306) -
This sequence change affects a donor splice site in intron 5 of the GNAS gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GNAS are known to be pathogenic (PMID: 11784876, 23281139, 23796510, 25802881). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with pseudopseudohypoparathyroidism (PMID: 7853365). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 446491). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. -
Inborn genetic diseases Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at